Navigation Links
Omeros Corporation Reports Fourth Quarter and Year-End 2010 Financial Results
Date:3/15/2011

urological product candidate OMS201 and the initiation of a program to advance a promising new antifibrinolytic agent to control surgical and traumatic bleeding," said Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "While our primary focus remains on reporting data from our OMS103HP Phase 3 ACL program later this quarter, we also look forward to reporting data from our Phase 2b ophthalmology trial of OMS302 in the coming weeks."

Fourth Quarter and Recent Highlights

  • Omeros received $20.0 million from Vulcan and a grant award for $5.0 million from the Life Sciences Discovery Fund of Washington State (LSDF) to support the advancement of the Company's GPCR program. In return, Vulcan and LSDF have a right to receive a percentage of net proceeds generated by the GPCR program. The Vulcan funding was obtained upon closing of the agreement; the LSDF funding will be drawn down as reimbursement for future qualified expenses.
  • Expanded its exclusive license to phosphodiesterase 7 (PDE7) inhibitors from Daiichi Sankyo Co., Ltd. to include the fields of addiction and compulsive disorders. Currently, Omeros is advancing PDE7 inhibitors for these indications as well as for movement disorders in collaboration with the National Institute on Drug Abuse and The Michael J. Fox Foundation, respectively.
  • Reported positive results from the Phase 1/Phase 2 clinical trial of OMS201, demonstrating that OMS201 was safe and well tolerated. OMS201 is the Company's PharmacoSurgery™ product candidate for use in urology.
  • Evaluated proof-of-concept models, and generated successful in vitro data, in connection with the series of compounds identified by Omeros that are functionally active at GPR87, an orphan GPCR linked to squamous cell carcinoma recently unlocked for drug development by the Company.
  • Announced the identification of compounds that interact selectively with two orphan GPCRs linked to pancreatic can
    '/>"/>

  • SOURCE Omeros Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
    2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
    3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
    4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
    5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
    6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
    7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
    8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
    9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
    10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
    11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
    (Date:9/29/2014)... YORK , Sept. 29, 2014 ... GlobalData,s new report, "EU5 Sigmoidoscopes Market Outlook ... EU5 Sigmoidoscopes market. The report provides value, in ... average prices (in US dollars) within market segments ... Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
    (Date:9/29/2014)... SAN DIEGO , 29 de septiembre ... aquí en adelante, Daiichi Sankyo) (TSE: 4568) y Ambit ... conjunta hoy que han llegado a un acuerdo de ... todas las acciones ordinarias de Ambit Biosciences a un ... medio de una oferta de licitación seguida de una ...
    Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3Daiichi Sankyo adquiere Ambit Biosciences 2Daiichi Sankyo adquiere Ambit Biosciences 3Daiichi Sankyo adquiere Ambit Biosciences 4Daiichi Sankyo adquiere Ambit Biosciences 5Daiichi Sankyo adquiere Ambit Biosciences 6Daiichi Sankyo adquiere Ambit Biosciences 7Daiichi Sankyo adquiere Ambit Biosciences 8
    ... 11, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... second development candidate, ISIS-AATRx, in its collaboration with GlaxoSmithKline ... payment from GSK for the selection of ISIS-AATRx.  ISIS-AATRx ... caused by alpha-1 antitrypsin deficiency, or AATD, by inhibiting ...
    ... 11, 2011 Reportlinker.com announces that ... available in its catalogue: ... http://www.reportlinker.com/p0358494/North-American-External-Defibrillator-Market.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices ... state of the North American external ...
    Cached Medicine Technology:Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 2Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 3Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 4North American External Defibrillator Market 2North American External Defibrillator Market 3North American External Defibrillator Market 4North American External Defibrillator Market 5North American External Defibrillator Market 6North American External Defibrillator Market 7
    (Date:9/29/2014)... NAPW honors Hope H. ... Year. She is recognized with this prestigious distinction for ... professional women in the country, the National Association of ... over 600,000 members and nearly 300 Local Chapters. , ... right about turn and applied to a university that ...
    (Date:9/29/2014)... 2014 NAPW honors ... Woman of the Year. Dr. Mondloch is recognized with ... medicine As the largest, most-recognized networking organization of professional ... profession, the National Association of Professional Women is a ... nearly 300 Local Chapters. , “Initially my goal was ...
    (Date:9/29/2014)... 30, 2014 NAPW honors ... Warm Hearts, Inc., as a 2014 Professional Woman of ... for leadership in home health services. As the largest, ... every industry and profession, the National Association of Professional ... over 600,000 members and nearly 300 Local Chapters. , ...
    (Date:9/29/2014)... 29, 2014 Every autumn, as high ... cross country running season takes off! Athletes typically train ... country running season. Zensah®, the leading compression apparel company, ... compression socks for cross country running. ... to reduce delayed onset muscle soreness (DOMS) throughout training ...
    (Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
    Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Hope H. Anderson, President of Hope Nutritional Services, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Victoria J. Mondloch, M.D., Family Medicine and Women's Health, a 2014 Professional Woman of the Year 2Health News:National Association of Professional Women Announces Rachel L. Gregus, Co-Founder of Safe Hands Warm Hearts, Inc., a 2014 Professional Woman of the Year 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2
    ... more stress can lead to the growth and spread of ... remarkable finding suggests that stress results in the release of ... released during stress stimulates cancer cells to produce two compounds ... the cells to move easily into the bloodstream and travel ...
    ... to treat seizures and migraine headaches, can increase the ... Southwestern Medical Center have found. ,A study – ... of topiramate affects kidney-stone formation – appears in the ... ,Several case reports have described an association ...
    ... from major depression can become symptom-free if they are ... treatments to determine which work best for them, which ... to the mix. ,The largest study on treatments ... that 67 percent of patients achieved a full remission ...
    ... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
    ... world-wide survey which has sought to understand sexual behaviors ... pre-marital sex //in the present day are baseless and ... of this survey are published in The Lancet. ... which showed that many had just a single recent ...
    ... been grown from umbilical cord blood stem cells for the ... animal experiments for drug testing. ,According to the ... is just the initial phase of generating segments that can ... a mature functioning form. ,Scientists from Newcastle ...
    Cached Medicine News:Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 2Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 3Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3Health News:Artificial Liver from Cord Blood Stem cells 2
    Micro-retractor arm 12"....
    ... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
    Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
    Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
    Medicine Products: